160 related articles for article (PubMed ID: 21732775)
1. Molecular diagnostics in melanoma: current status and perspectives.
Dadras SS
Arch Pathol Lab Med; 2011 Jul; 135(7):860-9. PubMed ID: 21732775
[TBL] [Abstract][Full Text] [Related]
2. Comparison of whole-exome sequencing of matched fresh and formalin fixed paraffin embedded melanoma tumours: implications for clinical decision making.
De Paoli-Iseppi R; Johansson PA; Menzies AM; Dias KR; Pupo GM; Kakavand H; Wilmott JS; Mann GJ; Hayward NK; Dinger ME; Long GV; Scolyer RA
Pathology; 2016 Apr; 48(3):261-6. PubMed ID: 27020503
[TBL] [Abstract][Full Text] [Related]
3. Differentiation of malignant melanoma from benign nevus using a novel genomic microarray with low specimen requirements.
Chandler WM; Rowe LR; Florell SR; Jahromi MS; Schiffman JD; South ST
Arch Pathol Lab Med; 2012 Aug; 136(8):947-55. PubMed ID: 22849744
[TBL] [Abstract][Full Text] [Related]
4. Molecular markers in melanoma.
Kashani-Sabet M
Br J Dermatol; 2014 Jan; 170(1):31-5. PubMed ID: 23815339
[TBL] [Abstract][Full Text] [Related]
5. BRAF mutation testing with a rapid, fully integrated molecular diagnostics system.
Janku F; Claes B; Huang HJ; Falchook GS; Devogelaere B; Kockx M; Bempt IV; Reijans M; Naing A; Fu S; Piha-Paul SA; Hong DS; Holley VR; Tsimberidou AM; Stepanek VM; Patel SP; Kopetz ES; Subbiah V; Wheler JJ; Zinner RG; Karp DD; Luthra R; Roy-Chowdhuri S; Sablon E; Meric-Bernstam F; Maertens G; Kurzrock R
Oncotarget; 2015 Sep; 6(29):26886-94. PubMed ID: 26330075
[TBL] [Abstract][Full Text] [Related]
6. Detection of copy number variations in melanocytic lesions utilising array based comparative genomic hybridisation.
Mesbah Ardakani N; Thomas C; Robinson C; Mina K; Harvey NT; Amanuel B; Wood BA
Pathology; 2017 Apr; 49(3):285-291. PubMed ID: 28274670
[TBL] [Abstract][Full Text] [Related]
7. Multi-center evaluation of the novel fully-automated PCR-based Idylla™ BRAF Mutation Test on formalin-fixed paraffin-embedded tissue of malignant melanoma.
Melchior L; Grauslund M; Bellosillo B; Montagut C; Torres E; Moragón E; Micalessi I; Frans J; Noten V; Bourgain C; Vriesema R; van der Geize R; Cokelaere K; Vercooren N; Crul K; Rüdiger T; Buchmüller D; Reijans M; Jans C
Exp Mol Pathol; 2015 Dec; 99(3):485-91. PubMed ID: 26407762
[TBL] [Abstract][Full Text] [Related]
8. [Molecular diagnostics in melanoma].
Lang R; Bauer JW; Laimer M
Hautarzt; 2015 Apr; 66(4):277-81. PubMed ID: 25783213
[TBL] [Abstract][Full Text] [Related]
9. Molecular diagnostics for ambiguous melanocytic tumors.
Shahbain H; Cooper C; Gerami P
Semin Cutan Med Surg; 2012 Dec; 31(4):274-8. PubMed ID: 23174498
[TBL] [Abstract][Full Text] [Related]
10. [Molecular diagnosis of melanocytic tumors].
Bauer J
Hautarzt; 2016 Jan; 67(1):59-63. PubMed ID: 26589514
[TBL] [Abstract][Full Text] [Related]
11. An Update Regarding the Molecular Genetics of Melanocytic Neoplasms and the Current Applications of Molecular Genetic Technologies in Their Diagnosis and Treatment.
Kiavash K; Bluth MH; Thompson AD
Clin Lab Med; 2018 Jun; 38(2):385-399. PubMed ID: 29776637
[TBL] [Abstract][Full Text] [Related]
12. Update in molecular diagnostics in melanocytic neoplasms.
Cooper C; Sorrell J; Gerami P
Adv Anat Pathol; 2012 Nov; 19(6):410-6. PubMed ID: 23060066
[TBL] [Abstract][Full Text] [Related]
13. Detection of Genetic Aberrations in the Assessment and Prognosis of Melanoma.
High WA
Dermatol Clin; 2017 Oct; 35(4):525-536. PubMed ID: 28886809
[TBL] [Abstract][Full Text] [Related]
14. Molecular Testing for Cutaneous Melanoma: An Update and Review.
Lee JJ; Lian CG
Arch Pathol Lab Med; 2019 Jul; 143(7):811-820. PubMed ID: 30354276
[TBL] [Abstract][Full Text] [Related]
15. Molecular Profiling in Cutaneous Melanoma.
Ji AL; Bichakjian CK; Swetter SM
J Natl Compr Canc Netw; 2016 Apr; 14(4):475-80. PubMed ID: 27059194
[TBL] [Abstract][Full Text] [Related]
16. Genomic aberrations in spitzoid melanocytic tumours and their implications for diagnosis, prognosis and therapy.
Wiesner T; Kutzner H; Cerroni L; Mihm MC; Busam KJ; Murali R
Pathology; 2016 Feb; 48(2):113-31. PubMed ID: 27020384
[TBL] [Abstract][Full Text] [Related]
17. Contemporary and potential future molecular diagnosis of melanoma.
Gandolfi G; Dallaglio K; Longo C; Moscarella E; Lallas A; Alfano R; Argenziano G; Ciarrocchi A
Expert Rev Mol Diagn; 2016 Sep; 16(9):975-85. PubMed ID: 27348706
[TBL] [Abstract][Full Text] [Related]
18. BRAF Mutation Testing in Cell-Free DNA from the Plasma of Patients with Advanced Cancers Using a Rapid, Automated Molecular Diagnostics System.
Janku F; Huang HJ; Claes B; Falchook GS; Fu S; Hong D; Ramzanali NM; Nitti G; Cabrilo G; Tsimberidou AM; Naing A; Piha-Paul SA; Wheler JJ; Karp DD; Holley VR; Zinner RG; Subbiah V; Luthra R; Kopetz S; Overman MJ; Kee BK; Patel S; Devogelaere B; Sablon E; Maertens G; Mills GB; Kurzrock R; Meric-Bernstam F
Mol Cancer Ther; 2016 Jun; 15(6):1397-404. PubMed ID: 27207774
[TBL] [Abstract][Full Text] [Related]
19. [Molecular and immunohistochemical diagnostics in melanoma].
Schilling B; Griewank KG
Hautarzt; 2016 Jul; 67(7):511-8. PubMed ID: 27270408
[TBL] [Abstract][Full Text] [Related]
20. High-resolution array-based comparative genomic hybridization for distinguishing paraffin-embedded Spitz nevi and melanomas.
Harvell JD; Kohler S; Zhu S; Hernandez-Boussard T; Pollack JR; van de Rijn M
Diagn Mol Pathol; 2004 Mar; 13(1):22-5. PubMed ID: 15163005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
